Can a coach-supported mobile health intervention reduce dementia risk?

FHS
May 21, 2024
9:56 am

Whether a coach-supported mHealth intervention can reduce dementia risk factors in high-risk, underserved populations.

Adcetris Plus Chemo Effective in HIV-Related Hodgkin Lymphoma

Brentuximab vedotin (Adcetris) in combination with doxorubicin, vinblastine, and dacarbazine (AVD) was effective for patients with HIV-related stages II-IV classical Hodgkin lymphoma (cHL), according to

August 5, 2023

Hunger hormone suppressed by intense exercise, study suggests

Research shows high-intensity exercise suppresses appetite by lowering ghrelin levels, with distinct responses observed between male and female participants.

October 28, 2024

Mubadala, CBC Group ink $680M deal for UCB’s neurology and allergy portfolio in China

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

August 27, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.